对帕金森病的客观测量与临床医生的评估
Andrea Guerra1, Valentina D'Onofrio2, Florinda Ferreri3,4
1Parkinson and Movement Disorder Unit, Study Center on Neurodegeneration (CESNE), Department of Neuroscience, University of Padua, Padua, Italy.
Expert review of neurotherapeutics
|June 27, 2023
概括
客观运动分析提供了一种比传统尺度更准确的方法来评估帕金森病 (PD) 运动症状. 这些工具有助于诊断,监测疾病进展,以及对PD患者的治疗决策.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 运动障碍 运动障碍
背景情况:
- 基于临床人员的尺度是帕金森病 (PD) 运动评估的标准,但具有诸如可变性等局限性.
- 客观运动分析越来越多地被认为具有提高PD评估的潜力.
研究的目的:
- 审查客观运动分析在量化和监测帕金森病运动症状的有用性.
- 讨论PD管理中的客观测量工具的临床应用.
主要方法:
- 对使用各种运动测量工具 (光电子,无接触,可穿戴系统) 的研究进行文献综述.
- 分析这些工具如何量化PD关键运动症状 (勃拉迪基尼西亚,刚性,震,步态).
- 检查确定PD患者的运动波动和并发症.
主要成果:
- 客观运动分析工具准确量化和监测PD运动症状和波动.
- 文献中的例子证明了光电子,无接触和可穿戴系统的有效性.
- 这些客观测量可以支持诊断和跟踪疾病的进展.
结论:
- 客观监测系统可以准确评估帕金森病的运动症状和并发症.
- 多种设备可以帮助诊断,监测和治疗PD的决策.
- 客观测量显著提高了临床和基于研究的PD评估的准确性.
更多相关视频
10:32Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
55.3K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.9K
相关概念视频
01:24Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
01:15Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607